已选(0)清除
条数/页: 排序方式:
|
| Genetic Algorithm Based Dynamics Modeling and Control of a Parallel Rehabilitation Robot 会议论文 巴西里约热内卢, 2018-7-8 作者: Wang, Chen; Peng, Liang; Hou, Zeng-guang 收藏  |  浏览/下载:19/0  |  提交时间:2018/10/14 |
| Model in frequency-domain identification of a fast steering mirror system based on levenberg-marquardt algorithm 会议论文 Chengdu, Sichuan, China, 2017-07-21 作者: Peng, Chen; Yanbing, Liang(梁雁冰); Peng, Chen (18363123192@163.com) 收藏  |  浏览/下载:23/0  |  提交时间:2018/06/12 |
| Deep-SENSE: Learning Coil Sensitivity Functions for SENSE Reconstruction Using Deep Learning 会议论文 巴黎, 2018年 作者: Xi Peng; Kevin Perkins; Bryan Clifford; Brad Sutton; Zhi-Pei Liang 收藏  |  浏览/下载:54/0  |  提交时间:2019/01/31 |
| A novel nanoparticle for improving the photodynamic effect of tumor anoxic environment 会议论文 上海, 2018 作者: Zhenguo Liang; Ping Gong; Qian Ren; Lintao Cai; Wenjun Li 收藏  |  浏览/下载:55/0  |  提交时间:2019/01/31 |
| Optimal Regularization Parameter Selection for Constrained Reconstruction Using Deep Learning 会议论文 巴黎, 2018年 作者: Xi Peng; Fan Lam; Yudu Li; Bryan Clifford; Brad Sutton 收藏  |  浏览/下载:20/0  |  提交时间:2019/01/31 |
| Constrained Dipole Inversion for Quantitative Susceptibility Mapping Using a "Kernel+Sparse" Model 会议论文 巴黎, 2018年 作者: Xi Peng; Yudu Li; Fan Lam; Rong Guo; Bryan Clifford 收藏  |  浏览/下载:23/0  |  提交时间:2019/01/31 |
| Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文 作者: Wei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang 收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05 |
| Long-Term Follow-up of Peginterferon alpha-2b (40kD, Y Shape) (Pegberon) Treatment of Hbeag-Positive Chronic Hepatitis B Patients in Phase III Study 会议论文 作者: 收藏  |  浏览/下载:18/0  |  提交时间:2019/12/05 |
| Identification of High Serum Apolipoprotein A1 As a Favorable Prognostic Indicator in Patients with Multiple Myeloma 会议论文 作者: Liu, Peng; Liang, Lifan; Li, Jing 收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05 |
| Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文 作者: Wei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang 收藏  |  浏览/下载:11/0  |  提交时间:2019/11/19 |